• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马约特岛的“Chimique”中存在合成大麻素MDMB - INACA:关于代谢的初步数据,以期开展未来基于废水的流行病学研究。

Presence of a synthetic cannabinoid, MDMB-INACA, in "Chimique" in Mayotte: preliminary data on metabolism with a view to a future epidemiological study based on wastewater.

作者信息

Gish Alexandr, Peyré Alexandre, Richeval Camille, Pleignet Eric, Cottereau Victoire, Gaulier Jean-Michel, Devault Damien Alain

机构信息

CHU Lille, Unité Fonctionnelle de Toxicologie, Lille, France.

Univ. Lille, URL 4483-IMPECS-IMPact de l'Environnement Chimique sur la Santé humaine, Lille, France.

出版信息

Environ Sci Pollut Res Int. 2025 Jul 30. doi: 10.1007/s11356-025-36789-3.

DOI:10.1007/s11356-025-36789-3
PMID:40736643
Abstract

Global consumption of new psychoactive substances is now reaching epidemic proportions. Among new psychoactive substances, synthetic cannabinoid receptor agonists challenge the monitoring framework due to the continuing growth in their numbers, which are increasing by around 20 molecules a year. We report data related to MDMB-INACA, a synthetic cannabinoid receptor agonist detected during the "Chasse-marée" study, carried out in Mayotte, a French overseas territory located in the Mozambique Channel: in addition to reporting its detection in samples of consumed products (called "Chimique") and to estimating consumer profiles via a self-administered questionnaire, we studied its metabolism in order to plan a wastewater monitoring project. In order to determine the involved molecules, sample of "Chimique" (the local name of a cigarette containing synthetic cannabinoids in the West Indian Ocean) were collected 1 week a month between September 22 and 23. Samples were collected from users by individual solicitation and a structured interview was proposed. Analyses were performed using liquid chromatography coupled with high-resolution mass spectrometry, and a metabolism study was carried out in silico and in vitro using human liver microsomes. One of the most found molecules was MDMB-INACA, often in tandem with MDMB-4en-PINACA. Sixty-four cigarettes contained MDMB-INACA out of 190 samples collected, and the mean concentration of MDMB-INACA in these samples of "Chimique" was 10.5 ± 13.6 µg/mg. The ultimate goal of this intensive fieldwork being to develop an epidemiology based on wastewater analysis, the MDMB-INACA metabolites were explored: the metabolite resulting from the hydrolysis of the carboxylic acid ester appears to be the most valuable target for wastewater-based epidemiology as MDMB-INACA biomarker. To a lesser extent, conjugated hepatic glucuronides (O-glucuronide metabolite and N-glucuronide metabolite) can serve as useful biomarkers for the analysis of biological media (blood, urine) from intoxicated victims, but their deconjugation in wastewater rules them out as analytical targets in wastewater-based epidemiological studies. This metabolite resulting from the hydrolysis of the carboxylic acid ester may be proposed as an analytical target for a wastewater monitoring project, but the present work also outlines the further studies needed to monitor MDMB-INACA in wastewater: metabolisation rates and in vitro, or even in situ, stability experiments need to be carried out.

摘要

新型精神活性物质的全球消费量现已达到流行程度。在新型精神活性物质中,合成大麻素受体激动剂对监测框架构成挑战,因为其数量持续增长,每年增加约20种分子。我们报告了与MDMB-INACA相关的数据,MDMB-INACA是在位于莫桑比克海峡的法国海外领地马约特岛进行的“Chasse-marée”研究中检测到的一种合成大麻素受体激动剂:除了报告其在消费产品(称为“Chimique”)样本中的检测情况,并通过自我管理问卷估计消费者概况外,我们还研究了其代谢情况,以便规划一个废水监测项目。为了确定相关分子,在9月22日至23日期间,每月收集1周的“Chimique”(西印度洋含合成大麻素香烟的当地名称)样本。通过个人邀约从使用者那里收集样本,并进行结构化访谈。使用液相色谱与高分辨率质谱联用进行分析,并使用人肝微粒体进行了计算机模拟和体外代谢研究。最常发现的分子之一是MDMB-INACA,通常与MDMB-4en-PINACA同时出现。在收集的190个样本中,有64支香烟含有MDMB-INACA,这些“Chimique”样本中MDMB-INACA的平均浓度为10.5±13.6μg/mg。这项密集实地调查的最终目标是基于废水分析开展流行病学研究,因此对MDMB-INACA的代谢物进行了探索:羧酸酯水解产生的代谢物似乎是基于废水的流行病学中作为MDMB-INACA生物标志物最有价值的目标。在较小程度上,共轭肝葡萄糖醛酸苷(O-葡萄糖醛酸苷代谢物和N-葡萄糖醛酸苷代谢物)可作为分析中毒受害者生物介质(血液、尿液)的有用生物标志物,但它们在废水中的去共轭作用使其无法作为基于废水的流行病学研究的分析目标。羧酸酯水解产生的这种代谢物可被提议作为废水监测项目的分析目标,但目前的工作也概述了在废水中监测MDMB-INACA所需的进一步研究:需要进行代谢率以及体外甚至原位稳定性实验。

相似文献

1
Presence of a synthetic cannabinoid, MDMB-INACA, in "Chimique" in Mayotte: preliminary data on metabolism with a view to a future epidemiological study based on wastewater.马约特岛的“Chimique”中存在合成大麻素MDMB - INACA:关于代谢的初步数据,以期开展未来基于废水的流行病学研究。
Environ Sci Pollut Res Int. 2025 Jul 30. doi: 10.1007/s11356-025-36789-3.
2
Data for the epidemiological study of CH-PIATA in wastewater from the study of its presence over 12 months in "la chimique" in Mayotte.
Environ Sci Pollut Res Int. 2025 Jul 12. doi: 10.1007/s11356-025-36689-6.
3
Waxy- or Putty-Like Materials as a Novel Drug Preparation for Synthetic Cannabinoid Receptor Agonists: Detection in Prisons and In Vitro Cannabinoid Receptor Activity.蜡状或油灰状物质作为合成大麻素受体激动剂的新型药物制剂:在监狱中的检测及体外大麻素受体活性
Drug Test Anal. 2024 Oct 15. doi: 10.1002/dta.3817.
4
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
From the curb to the curve: population exposure to the synthetic cannabinoid receptor agonist MDMB-4en-PINACA in Mayotte.
Environ Sci Pollut Res Int. 2025 Jul 16. doi: 10.1007/s11356-025-36744-2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.